We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SRAMF market cap is 177.97M. The company's latest EPS is USD 0.0673 and P/E is 5.65.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 173.52M | 162.1M | 294.29M | 354.48M | 359.29M |
| Operating Income | 23.17M | 16.6M | 42.45M | 44.89M | 37.61M |
| Net Income | 20.79M | 13.34M | 31.25M | 40.17M | 31.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 393.48M | 431.81M | 530.13M | 555.6M | 613.5M |
| Total Liabilities | 67.91M | 99.92M | 126.51M | 123.38M | 143.98M |
| Total Equity | 325.57M | 331.89M | 403.63M | 432.23M | 469.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 21.04M | 25.74M | 32.38M | 22.04M | 43.94M |
| Investing | 53.69M | -33.51M | -46.77M | -52.11M | -33M |
| Financing | -9.36M | -12.21M | 55.78M | -17.85M | -20.97M |
| Market Cap | 177.97M |
| Price to Earnings Ratio | 5.65 |
| Price to Sales Ratio | 0.5 |
| Price to Cash Ratio | 2.52 |
| Price to Book Ratio | 0.38 |
| Dividend Yield | - |
| Shares Outstanding | 468.34M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.48 (83.6%) |
| Company Name | Sisram Medical Ltd (PK) |
| Address |
14 halamish street haifa, north |
| Website | https://sisram-medical.com |
| Industry | health practitioners, nec (8049) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
